Phase III is intended to generate meaningful biological data on potential drug compounds prioritized by YuvaBio’s classifier, ...
AI changes everything. Higher ed is facing that with anxiety but not enough with action to help students and institutional ...
The Women in AI Healthcare event series - hosted by Real Chemistry in collaboration with Pharma Brands – brings together ...
AI is reshaping the CHRO role, requiring HR leaders to become AI strategists and bridge people, technology, and data in today ...
Maolac is not designed to imitate human milk, but to understand its biological advantages. Using a proprietary AI-driven ...
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Dr Alan Roth, CEO of Oxford Drug Design, about the use ...
TipRanks on MSN
PMGC Holdings advances AI-driven obesity drug program
PMGC Holdings ( ($ELAB) ) just unveiled an update. On December 17, 2025, NorthStrive Biosciences, a subsidiary of PMGC Holdings, announced it had ...
Investors say Microsoft's real edge comes from its sprawling AI ecosystem and growing independence from any single model ...
Adopting AI with FinOps principles in mind grants financial visibility, alignment across teams, cost control and the ability ...
An assumption propelling a proposed recalibration of European tech regulation is that red tape is holding back the trading ...
In a world that’s constantly shifting, self-awareness is your competitive edge. Author Tasha Eurich told the Harvard Business ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback